A new clinical study endorses Curcugen’s role as a compelling post-workout anti-inflammatory agent
DolCas Biotech LLC’s novel Curcugen curcumin formulation is being primed for the sports health sector. Newly armed with self-affirmed GRAS designation as a safe, functional food ingredient, Curcugen is poised to feature in a comprehensive portfolio of sports supplements and post-workout bars, shakes, and beverages. A new clinical study endorses Curcugen’s role as a compelling post-workout anti-inflammatory agent.
Curcugen demonstrates anti-inflammatory role in acute exercise model
Results of clinical research published in the proceedings of the Seventeenth International Society of Sports Nutrition (ISSN) Conference and Expo, December 2020, confirmed Curcugen’s positive anti-inflammatory, anti-oxidant and analgesic capacity on subjects engaging in acute exercise. In this double-blinded, placebo-controlled study, led by Neil Schwarz, PhD, 24 participants were randomized to either a daily dose of 500 mg of Curcugen or the equivalent dose in rice flour prior to an intense exercise protocol of 50 hurdles and 50 drop jumps. Joint range-of-motion (ROM), soreness, and markers of inflammation and oxidative stress where significantly better in the Curcugen group 72 hours post-exercise demonstrating its capabilities in accelerating post-workout recovery.
The role of curcumin in pre/post-workout supplements
Science affirms the botanical’s unquestionable positive impact on mitigating the negative effects of high-intensity exercises. It appears that these exercises lead to an overwhelming free radical/oxidative stress response that incites tissue-damaging inflammation, subsequently prolonging healing and recovery. Curcumin has been found to offer superior antioxidant benefits to the tissues, quelling the inflammatory response. Studies have confirmed this effect via the reduced presence of blood serum inflammatory markers during the post-exercise period, and reports of reduced pain sided by a speedy return to physical activity when compared to placebo.